Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Medication 1.4.3 Physical Therapy 1.4.4 Speech Therapy 1.4.5 Others 1.5 Market by Application 1.5.1 Global Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Specialty Centers 1.5.4 Research Centers 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Amyotrophic Lateral Sclerosis Treatment Market Size 2.2 Amyotrophic Lateral Sclerosis Treatment Growth Trends by Regions 2.2.1 Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (2014-2025) 2.2.2 Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Amyotrophic Lateral Sclerosis Treatment Market Size by Manufacturers 3.1.1 Global Amyotrophic Lateral Sclerosis Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Area Served 3.3 Key Players Amyotrophic Lateral Sclerosis Treatment Product/Solution/Service 3.4 Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) 4.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 5.2 Amyotrophic Lateral Sclerosis Treatment Key Players in United States 5.3 United States Amyotrophic Lateral Sclerosis Treatment Market Size by Type 5.4 United States Amyotrophic Lateral Sclerosis Treatment Market Size by Application 6 Europe 6.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 6.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Europe 6.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type 6.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application 7 China 7.1 China Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 7.2 Amyotrophic Lateral Sclerosis Treatment Key Players in China 7.3 China Amyotrophic Lateral Sclerosis Treatment Market Size by Type 7.4 China Amyotrophic Lateral Sclerosis Treatment Market Size by Application 8 Japan 8.1 Japan Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 8.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Japan 8.3 Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Type 8.4 Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 9.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Southeast Asia 9.3 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Type 9.4 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Application 10 India 10.1 India Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 10.2 Amyotrophic Lateral Sclerosis Treatment Key Players in India 10.3 India Amyotrophic Lateral Sclerosis Treatment Market Size by Type 10.4 India Amyotrophic Lateral Sclerosis Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size (2014-2019) 11.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Central & South America 11.3 Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Type 11.4 Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Application 12 International Players Profiles 12.1 Sanofi 12.1.1 Sanofi Company Details 12.1.2 Company Description and Business Overview 12.1.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.1.5 Sanofi Recent Development 12.2 Roche 12.2.1 Roche Company Details 12.2.2 Company Description and Business Overview 12.2.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.2.4 Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.2.5 Roche Recent Development 12.3 Biogen 12.3.1 Biogen Company Details 12.3.2 Company Description and Business Overview 12.3.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.3.4 Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.3.5 Biogen Recent Development 12.4 Mitsubishi Tanabe Pharma 12.4.1 Mitsubishi Tanabe Pharma Company Details 12.4.2 Company Description and Business Overview 12.4.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.4.5 Mitsubishi Tanabe Pharma Recent Development 12.5 GNT Pharma 12.5.1 GNT Pharma Company Details 12.5.2 Company Description and Business Overview 12.5.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.5.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.5.5 GNT Pharma Recent Development 12.6 Synthetic Biologics 12.6.1 Synthetic Biologics Company Details 12.6.2 Company Description and Business Overview 12.6.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.6.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.6.5 Synthetic Biologics Recent Development 12.7 Amkor Pharma 12.7.1 Amkor Pharma Company Details 12.7.2 Company Description and Business Overview 12.7.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.7.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.7.5 Amkor Pharma Recent Development 12.8 ViroMed 12.8.1 ViroMed Company Details 12.8.2 Company Description and Business Overview 12.8.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.8.4 ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.8.5 ViroMed Recent Development 12.9 Brainstorm Therapeutics 12.9.1 Brainstorm Therapeutics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.9.4 Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.9.5 Brainstorm Therapeutics Recent Development 12.10 Valeant Pharmaceuticals 12.10.1 Valeant Pharmaceuticals Company Details 12.10.2 Company Description and Business Overview 12.10.3 Amyotrophic Lateral Sclerosis Treatment Introduction 12.10.4 Valeant Pharmaceuticals Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) 12.10.5 Valeant Pharmaceuticals Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Amyotrophic Lateral Sclerosis Treatment Key Market Segments Table Key Players Amyotrophic Lateral Sclerosis Treatment Covered Table Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type 2014-2025 Figure Medication Figures Table Key Players of Medication Figure Physical Therapy Figures Table Key Players of Physical Therapy Figure Speech Therapy Figures Table Key Players of Speech Therapy Figure Others Figures Table Key Players of Others Table Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Specialty Centers Case Studies Figure Research Centers Case Studies Figure Others Case Studies Figure Amyotrophic Lateral Sclerosis Treatment Report Years Considered Table Global Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2025 (Million US$) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions 2014-2019 Figure Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions 2014-2019 Figure Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Amyotrophic Lateral Sclerosis Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Amyotrophic Lateral Sclerosis Treatment Market Share by Manufacturers (2014-2019) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Share by Manufacturers in 2018 Table Global Amyotrophic Lateral Sclerosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Amyotrophic Lateral Sclerosis Treatment Product/Solution/Service Table Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Type (2014-2019) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2014-2019) Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Application (2014-2019) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2014-2019) Figure Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Application in 2018 Figure United States Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table United States Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table United States Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table United States Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table United States Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Figure Europe Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Figure China Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table China Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table China Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table China Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-20189) (Million US$) Table China Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table China Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table China Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Figure Japan Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Figure Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Figure India Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table India Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table India Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table India Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table India Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table India Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table India Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Figure Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2018-2019) Table Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2014-2019) Table Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2014-2019) Table Sanofi Company Details Table Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) (Million US$) Figure Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Sanofi Recent Development Table Roche Company Details Table Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Roche Recent Development Table Biogen Company Details Table Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Biogen Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Biogen Recent Development Table Mitsubishi Tanabe Pharma Company Details Table Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Mitsubishi Tanabe Pharma Recent Development Table GNT Pharma Company Details Table GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table GNT Pharma Recent Development Table Synthetic Biologics Company Details Table Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Synthetic Biologics Recent Development Table Amkor Pharma Company Details Table Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Amkor Pharma Recent Development Table ViroMed Company Details Table ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure ViroMed Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table ViroMed Recent Development Table Brainstorm Therapeutics Company Details Table Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Brainstorm Therapeutics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Brainstorm Therapeutics Recent Development Table Valeant Pharmaceuticals Company Details Table Valeant Pharmaceuticals Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019)(Million US$) Figure Valeant Pharmaceuticals Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2014-2019) Table Valeant Pharmaceuticals Recent Development Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Regions (2019-2025) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Regions in 2025 Figure United States Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size by Product (2019-2025) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size by Product in 2025 Table Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2025) Figure Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Roche Biogen Mitsubishi Tanabe Pharma GNT Pharma Synthetic Biologics Amkor Pharma ViroMed Brainstorm Therapeutics Valeant Pharmaceuticals